Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

K. Sarnow; S. G. Schwab; O. Rio; J. Mukherjee; R. Bjerkvig; T. A. Johannessen

doi:10.1093/neuonc/noab180.195

Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

K. Sarnow, S. G. Schwab, O. Rio, J. Mukherjee, R. Bjerkvig, T. A. Johannessen

Department of Cancer Research

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	P15.02
Pages (from-to)	56-56
Journal	Neuro-Oncology
Volume	23
Issue number	Suppl.2
DOIs	https://doi.org/10.1093/neuonc/noab180.195
Publication status	Published - Sept 2021
Event	16th Meeting of the European Association of Neuroncology (EANO) Virtual congress - Duration: 25 Sept 2021 → 26 Sept 2021

Access to Document

10.1093/neuonc/noab180.195

Cite this

@article{71c84355ea7e4896a694c5681d796077,

title = "Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression",

author = "K. Sarnow and Schwab, {S. G.} and O. Rio and J. Mukherjee and R. Bjerkvig and Johannessen, {T. A.}",

year = "2021",

month = sep,

doi = "10.1093/neuonc/noab180.195",

language = "English",

volume = "23",

pages = "56--56",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Suppl.2",

note = "16th Meeting of the European Association of Neuroncology (EANO) Virtual congress ; Conference date: 25-09-2021 Through 26-09-2021",

}

TY - JOUR

T1 - Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

AU - Sarnow, K.

AU - Schwab, S. G.

AU - Rio, O.

AU - Mukherjee, J.

AU - Bjerkvig, R.

AU - Johannessen, T. A.

PY - 2021/9

Y1 - 2021/9

U2 - 10.1093/neuonc/noab180.195

DO - 10.1093/neuonc/noab180.195

M3 - Meeting Abstract

SN - 1522-8517

VL - 23

SP - 56

EP - 56

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Suppl.2

M1 - P15.02

T2 - 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress

Y2 - 25 September 2021 through 26 September 2021

ER -